🇺🇸 FDA
Patent

US 10556875

Bis-diazeniumdiolate compounds as anti-cancer agents

granted A61PA61P35/00

Quick answer

US patent 10556875 (Bis-diazeniumdiolate compounds as anti-cancer agents) held by ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY expires Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY
Grant date
Tue Feb 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61P, A61P35/00